Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-26-062728
Filing Date
2026-05-15
Accepted
2026-05-15 16:47:20
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 16395
  Complete submission text file 0001104659-26-062728.txt   17994
Mailing Address 830 BRICKELL PLAZA MIAMI FL 33131
Business Address 830 BRICKELL PLAZA MIAMI FL 33131 305-929-6851
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Subject) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93824 | Film No.: 26989135
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)